Mettler-Toledo International (NYSE:MTD) Receives New Coverage from Analysts at Barclays

Research analysts at Barclays began coverage on shares of Mettler-Toledo International (NYSE:MTD) in a research report issued to clients and investors on Thursday, January 4th, MarketBeat reports. The brokerage set an “equal weight” rating and a $625.00 price target on the medical instruments supplier’s stock. Barclays’ price objective would suggest a potential downside of 6.25% from the company’s previous close.

Several other analysts have also issued reports on the company. Evercore ISI began coverage on Mettler-Toledo International in a report on Wednesday, January 3rd. They set an “in-line” rating and a $625.00 target price on the stock. Zacks Investment Research lowered Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Tuesday, November 7th. Morgan Stanley upped their target price on Mettler-Toledo International from $535.00 to $545.00 and gave the stock an “equal weight” rating in a report on Friday, November 3rd. Robert W. Baird upped their target price on Mettler-Toledo International from $605.00 to $675.00 and gave the stock a “neutral” rating in a report on Friday, November 3rd. Finally, Jefferies Group reissued a “hold” rating and set a $600.00 price target on shares of Mettler-Toledo International in a research report on Friday, October 20th. Six research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $647.63.

Shares of Mettler-Toledo International (NYSE MTD) traded up $12.94 during trading on Thursday, hitting $666.69. The stock had a trading volume of 188,638 shares, compared to its average volume of 133,045. The company has a market capitalization of $16,722.35, a price-to-earnings ratio of 40.45, a price-to-earnings-growth ratio of 2.63 and a beta of 1.09. Mettler-Toledo International has a 12 month low of $408.97 and a 12 month high of $694.48. The company has a current ratio of 1.51, a quick ratio of 1.11 and a debt-to-equity ratio of 2.05.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $4.36 EPS for the quarter, beating analysts’ consensus estimates of $4.32 by $0.04. The company had revenue of $698.80 million for the quarter, compared to analyst estimates of $685.56 million. Mettler-Toledo International had a return on equity of 96.81% and a net margin of 16.44%. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the company posted $3.89 earnings per share. analysts expect that Mettler-Toledo International will post 17.52 earnings per share for the current fiscal year.

In other Mettler-Toledo International news, insider Simon Kirk sold 4,726 shares of the company’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $629.01, for a total transaction of $2,972,701.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael A. Kelly sold 3,384 shares of the stock in a transaction on Monday, November 6th. The shares were sold at an average price of $638.24, for a total value of $2,159,804.16. Following the completion of the transaction, the director now owns 4,762 shares of the company’s stock, valued at $3,039,298.88. The disclosure for this sale can be found here. Insiders have sold 39,969 shares of company stock worth $25,242,999 in the last three months. 5.20% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Commonwealth Bank of Australia lifted its stake in shares of Mettler-Toledo International by 3.1% in the 2nd quarter. Commonwealth Bank of Australia now owns 562 shares of the medical instruments supplier’s stock valued at $329,000 after acquiring an additional 17 shares during the last quarter. Profund Advisors LLC increased its holdings in Mettler-Toledo International by 2.6% in the second quarter. Profund Advisors LLC now owns 716 shares of the medical instruments supplier’s stock valued at $421,000 after purchasing an additional 18 shares during the period. Pacer Advisors Inc. increased its holdings in Mettler-Toledo International by 6.4% in the second quarter. Pacer Advisors Inc. now owns 483 shares of the medical instruments supplier’s stock valued at $284,000 after purchasing an additional 29 shares during the period. Suntrust Banks Inc. increased its holdings in Mettler-Toledo International by 4.9% in the second quarter. Suntrust Banks Inc. now owns 900 shares of the medical instruments supplier’s stock valued at $529,000 after purchasing an additional 42 shares during the period. Finally, Columbia Asset Management increased its holdings in Mettler-Toledo International by 3.0% in the second quarter. Columbia Asset Management now owns 1,539 shares of the medical instruments supplier’s stock valued at $905,000 after purchasing an additional 45 shares during the period. Institutional investors own 91.67% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Mettler-Toledo International (NYSE:MTD) Receives New Coverage from Analysts at Barclays” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/01/20/mettler-toledo-international-mtd-coverage-initiated-by-analysts-at-barclays.html.

About Mettler-Toledo International

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply